PubRank

L Makowka

Author PubWeight™ 264.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 1988 5.77
2 Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery 1988 5.03
3 An improved technique for multiple organ harvesting. Surg Gynecol Obstet 1987 4.73
4 IMMUNOSUPPRESSION WITH FR 900506 FOR CANINE KIDNEY AND LIVER TRANSPLANTATION. Surg Res Commun 1987 4.68
5 Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc 1987 4.21
6 Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc 1987 3.73
7 Transplantation of multiple abdominal viscera. JAMA 1989 3.59
8 IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. Surg Res Commun 1987 3.46
9 The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988 3.24
10 Liver transplantation before 1 year of age. J Pediatr 1987 3.15
11 In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc 1988 3.15
12 A multifactorial system for equitable selection of cadaver kidney recipients. JAMA 1987 3.01
13 Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc 1988 2.87
14 Equitable allocation of extrarenal organs: with special reference to the liver. Transplant Proc 1988 2.85
15 The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation 1990 2.79
16 Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis 1988 2.76
17 THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS. Surg Res Commun 1987 2.75
18 Toxicology of FK-506 in the Lewis rat. Transplant Proc 1987 2.37
19 The hepatotropic influence of cyclosporine. Surgery 1990 2.27
20 Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation 1993 2.17
21 Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg 1987 2.11
22 Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc 1987 1.90
23 Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 1988 1.89
24 Hepatic artery in liver transplantation. Transplant Proc 1987 1.73
25 The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988 1.72
26 Hepatic artery thrombosis after pediatric liver transplantation--a medical or surgical event? Transplantation 1989 1.67
27 Cyclosporine A augments the regenerative response after partial hepatectomy in the rat. Transplant Proc 1988 1.64
28 Liver transplantation: an unfinished product. Transplant Proc 1989 1.61
29 Microbiological hazards related to xenotransplantation of porcine organs into man. Infect Control Hosp Epidemiol 1998 1.58
30 Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989 1.58
31 The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg 1988 1.56
32 FK-506 enhances cyclosporine uptake by peripheral blood lymphocytes. Transplant Proc 1987 1.56
33 Occurrence of cytomegalovirus hepatitis in liver transplant patients. J Med Virol 1988 1.50
34 Extraction and partial purification of a hepatic stimulatory substance in rats, mice, and dogs. Cancer Res 1987 1.43
35 Prostaglandins in liver failure and transplantation: regeneration, immunomodulation, and cytoprotection. Prostaglandins in Liver Transplantation Research Group. Liver Transpl Surg 1996 1.43
36 Nutritional support after liver transplantation: a randomized prospective study. JPEN J Parenter Enteral Nutr 1990 1.43
37 Nonspecific and selective stimulation of the immune system in the treatment of carcinoma in humans. Can Med Assoc J 1983 1.39
38 Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies. Transplant Proc 1988 1.38
39 Examination of patient selection and outcome for hepatic resection for metastatic disease. Surg Gynecol Obstet 1987 1.37
40 Rapid Flush Technique for Donor Hepatectomy: Safety and Efficacy of an Improved Method of Liver Recovery for Transplantation. Transplant Proc 1988 1.37
41 Impact of Orthoclone OKT3 on liver transplantation. Transplant Proc 1987 1.36
42 OKT3 in the reversal of acute hepatic allograft rejection. Transplant Proc 1987 1.35
43 Biopharmaceutical aspects of FK-506. Transplant Proc 1987 1.34
44 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest 1987 1.33
45 Sensitivity of activated human lymphocytes to cyclosporine and its metabolites. Hum Immunol 1988 1.31
46 Excretion of cyclosporine and its metabolites in human bile. Transplant Proc 1986 1.27
47 Analysis of surgical complications after 397 hepatic transplantations. Surg Gynecol Obstet 1990 1.25
48 Fungal Infections After Liver Transplantation. Transplant Proc 1988 1.24
49 The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat. Transplantation 1992 1.23
50 Experience with primary liver transplantation across ABO blood groups. Transplant Proc 1987 1.23
51 Markers of allograft viability in the rat. Relationship between transplantation viability and liver function in the isolated perfused liver. Transplantation 1987 1.20
52 Renal artery reconstruction for harvesting injuries in kidney transplantation with particular reference to the use of vascular allografts. Transpl Int 1988 1.14
53 The definition of ABO factors in transplantation: relation to other humoral antibody states. Transplant Proc 1987 1.13
54 Liver transplantation in patients with patent splenorenal shunts. Surgery 1987 1.12
55 Transplantation for primary biliary cirrhosis. Gastroenterology 1988 1.12
56 Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis. Transplantation 1989 1.12
57 Indications for pediatric liver transplantation. J Pediatr 1987 1.12
58 Liver transplantation in the treatment of bleeding esophageal varices. Surgery 1988 1.11
59 Lymphocytic subsets and histopathologic changes associated with the development of heart transplant arteriosclerosis. J Heart Lung Transplant 1992 1.09
60 Improved hepatic function in the 24-hour preserved rat liver with UW-lactobionate solution and SRI 63-441. Gastroenterology 1988 1.08
61 Purine nucleoside phosphorylase: a new marker for free oxygen radical injury to the endothelial cell. Hepatology 1990 1.04
62 Reversal of toxic and anoxic induced hepatic failure by syngeneic, allogeneic, and xenogeneic hepatocyte transplantation. Surgery 1980 1.03
63 A clinicopathologic study of primary hepatic carcinoid tumors. Cancer 1990 1.02
64 Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation 1989 1.02
65 Cellular transplantation in the treatment of experimental hepatic failure. Science 1980 1.01
66 Liver transplantation: where it's been and where it's going. Gastroenterol Clin North Am 1988 1.01
67 The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro. Hepatology 1989 1.01
68 Renal Transplantation in the Presence of a Positive Cytotoxic Antibody. Transplant Proc 1988 0.99
69 The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine. Hepatology 1987 0.99
70 Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg 1989 0.99
71 Liver transplantation for fulminant hepatic failure. Transplant Proc 1989 0.98
72 A dog model for acetaminophen-induced fulminant hepatic failure. Gastroenterology 1989 0.98
73 Impact of OKT3 Therapy on Cytomegalovirus and Herpes Simplex Virus Infections After Liver Transplantation. Transplant Proc 1988 0.97
74 Thrombosis of the portal vein following distal splenorenal shunt. Surg Gynecol Obstet 1979 0.97
75 Acute liver failure due to lymphoma. A diagnostic concern when considering liver transplantation. Dig Dis Sci 1994 0.97
76 Small intestinal transplantation using cyclosporine. Report of a case. Transplantation 1986 0.96
77 Gender of donor influences outcome after orthotopic liver transplantation in adults. Dig Dis Sci 1993 0.96
78 Applications of the isolated perfused rat liver in transplantation research. J Invest Surg 1988 0.95
79 Is multiple organ failure a contraindication for liver transplantation in children? Transplant Proc 1987 0.95
80 Immunosuppressive effect of cyclosporine metabolites from human bile on alloreactive T cells. Transplant Proc 1988 0.95
81 Late mortality and morbidity after liver transplantation. Transplant Proc 1987 0.95
82 Protective effect of the lazaroid U74006F in cold ischemia-reperfusion injury of the liver. Hepatology 1994 0.95
83 Self-limited Toxoplasma parasitemia after liver transplantation. Transplantation 1987 0.94
84 Pathologic analysis of liver transplantation for primary biliary cirrhosis. Hepatology 1988 0.94
85 Comparison of the antitumor effects of a synthetic biopolymer and standard adjuvants. Surgery 1980 0.94
86 Hepatocellular adenoma in glycogen storage disease type IV. Arch Pathol Lab Med 1994 0.93
87 Liver replacement after massive hepatic trauma. J Trauma 1987 0.92
88 Prevention of cyclosporine (CyA) nephrotoxicity by synthetic prostaglandins. Clin Nephrol 1986 0.92
89 Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet 1993 0.92
90 Pharmacologic modulation of experimental postischemic hepatic function. Ann Surg 1989 0.92
91 Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. N Engl J Med 1988 0.92
92 Hepatic angiomyolipoma: two case reports of caudate-based lesions and review of the literature. Liver Transpl Surg 1997 0.91
93 Liver transplantation in children. Am J Gastroenterol 1994 0.91
94 Pancreatitis following liver transplantation. Transplantation 1988 0.90
95 Lymphocytes infiltrating rat cardiac allografts express a limited repertoire of T cell receptor V beta genes. J Immunol 1993 0.90
96 Antibody deposition in liver allografts with chronic rejection. Transplant Proc 1987 0.90
97 Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection. Transplantation 1995 0.90
98 A comparison of lymphocytic subsets participating in concordant cardiac xenograft and acute cardiac allograft rejection. Transplant Proc 1992 0.90
99 Arterial mycotic aneurysm and rupture. A potentially fatal complication of pancreas transplantation in diabetes mellitus. Arch Surg 1989 0.90
100 Isolation and primary cultures of human intrahepatic bile ductular epithelium. In Vitro Cell Dev Biol 1988 0.90
101 Mechanism of increased antitumor immunity by a synthetic polymer. J Surg Res 1980 0.89
102 Modulation of the immune response and control of tumour spread by a new synthetic compound. Br J Surg 1979 0.89
103 Acute human immunodeficiency virus infection. Antigen detection and seroconversion in immunosuppressed patients. Transplantation 1989 0.89
104 Allogeneic hepatocyte transplantation in the rat spleen under cyclosporine immunosuppression. Transplantation 1986 0.88
105 Regulation of liver size and regeneration: importance in liver transplantation. Transplant Proc 1988 0.88
106 Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group. Transplantation 1997 0.88
107 Cardiac transplantation in the rat. II. Alteration of the severity of donor graft arteriosclerosis by modulation of the host immune response. Transplantation 1990 0.87
108 Accidental transplantation of malignant tumor from a donor to multiple recipients. Transplantation 1987 0.87
109 Studies into the mechanism of reversal of experimental acute hepatic failure by hepatocyte transplantation. 1. Can J Surg 1981 0.87
110 Effect of OKT3 on survival and rate of retransplantation. Transplant Proc 1987 0.87
111 The prolongation of concordant hamster-to-rat cardiac xenografts by brequinar sodium. Transplantation 1992 0.86
112 Lipid peroxidation is a nonparenchymal cell event with reperfusion after prolonged liver ischemia. J Surg Res 1990 0.86
113 FK 506 inhibits the development of transplant arteriosclerosis. Transplant Proc 1991 0.86
114 Clonal characteristics of posttransplant lymphoproliferative disorders. Transplant Proc 1988 0.86
115 Liver transplantation in patients with previous portasystemic shunt. Am J Surg 1990 0.86
116 Hyperacute rejection of the kidney in patients with a negative crossmatch. Transplant Proc 1988 0.86
117 Primary lymphoma of the liver showing immunohistochemical evidence of T-cell origin. Successful management by right trisegmentectomy. Dig Dis Sci 1988 0.85
118 Cyclosporine immunosuppression and delayed graft function in 455 cadaveric renal transplants. Transplant Proc 1987 0.85
119 Metastasis of hepatocellular carcinoma to the right colon manifested by gastrointestinal bleeding. Am Surg 1999 0.85
120 Induction of stable chimerism and elimination of graft-versus-host disease by depletion of T lymphocytes from bone marrow using immunomagnetic beads. Surgery 1989 0.85
121 The characterization and partial purification of hepatocyte proliferation factor. Ann Surg 1985 0.85
122 Significance of blood flow measurement in clinical liver transplantation. Transplant Proc 1989 0.85
123 Hepatic regeneration: current concepts and clinical implications. Semin Liver Dis 1994 0.84
124 Reversal of experimental acute hepatic failure in the rat. J Surg Res 1980 0.84
125 Reversal of lethal, chemotherapeutically induced acute hepatic necrosis in rats by regenerating liver cytosol. Surgery 1983 0.84
126 Estradiol and testosterone levels in patients undergoing partial hepatectomy. A possible signal for hepatic regeneration? Dig Dis Sci 1989 0.84
127 Posttransplantation cyclosporine-induced lymphoproliferative disorders: clinical and radiologic manifestations. Radiology 1987 0.83
128 Progress in liver transplantation. Adv Surg 1988 0.83
129 A new liver perfusion and preservation system for transplantation research in large animals. J Invest Surg 1990 0.83
130 Orthotopic liver transplantation for alpha-1-antitrypsin deficiency: an experience in 29 children and ten adults. Transplant Proc 1987 0.83
131 Reversal of cyclosporine-induced mortality with a synthetic polymeric immunostimulant in a murine model of fecal peritonitis. Transplantation 1985 0.83
132 Liver transplantation for primary biliary cirrhosis. Semin Liver Dis 1989 0.83
133 Orthotopic liver transplantation and the cytosolic estrogen-androgen receptor status of the liver: the influence of the sex of the donor. Hepatology 1989 0.83
134 Structure and diversity of rat T cell receptor alpha-chain genes. J Immunol 1993 0.83
135 Effect of an antiandrogenic H2 receptor antagonist on hepatic regeneration in rats. J Lab Clin Med 1988 0.83
136 Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism. Transplantation 1996 0.82
137 Transarterial chemoembolization is a safe treatment for unresectable hepatic malignancies. Am Surg 1997 0.82
138 Late surgical complications of choledochal cystoenterostomy. Am Surg 1994 0.82
139 The effect of liver cytosol on hepatic regeneration and tumor growth. Cancer 1983 0.82
140 Factors responsible for hepatic artery thrombosis after pediatric liver transplantation. Transplant Proc 1989 0.82
141 Improved preservation of the rat liver for orthotopic liver transplantation: use of University of Wisconsin-lactobionate solution and retrograde reflushing. Surgery 1990 0.82
142 Treatment of the postoperative alcoholic liver transplant recipient with other addictions. Liver Transpl Surg 1997 0.82
143 Further experience with regional radiofrequency hyperthermia and cytotoxic chemotherapy for unresectable hepatic neoplasia. Cancer 1985 0.82
144 Analysis of the T-cell receptor V beta repertoire in rejecting rat cardiac allografts using a quantitative polymerase chain reaction. Transplant Proc 1993 0.81
145 Removal of natural human xenoantibodies to pig vascular endothelium by perfusion of blood through pig kidneys and livers. Transplantation 1993 0.81
146 Orthotopic liver transplantation for massive hepatic lymphangiomatosis. Surgery 1988 0.81
147 Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation. Liver Transpl Surg 1997 0.81
148 A Novel Model of Acute Hepatic Failure in Dogs With Implications for Transplantation Research. Transplant Proc 1988 0.81
149 Cyclosporine augments hepatic regenerative response in rats. Dig Dis Sci 1990 0.81
150 Is hepatic artery thrombosis after liver transplantation really a surgical complication? Transplant Proc 1989 0.81
151 Hepatitis C virus is not recoverable from liver tissue in cryptogenic cirrhosis: failure to identify hepatitis C virus-RNA using reverse transcription-mediated polymerase chain reaction. Hum Pathol 1996 0.81
152 Significance of lecithin:cholesterol acyltransferase activity as a prognostic indicator of early allograft function in clinical liver transplantation. Transplantation 1989 0.81
153 Protection of thermochemotherapeutic-induced lethal acute hepatic necrosis in the rat by 16,16-dimethyl prostaglandin E2. J Surg Res 1983 0.80
154 Allogeneic and xenogeneic hepatocyte transplantation in experimental hepatic failure. Transplantation 1980 0.80
155 Liver transplantation for tyrosinemia. A review of 10 cases from the University of Pittsburgh. Dig Dis Sci 1990 0.80
156 Experience with Orthoclone OKT3 monoclonal antibody in liver transplantation. Am J Kidney Dis 1988 0.80
157 The effect of a new immunosuppressive drug, brequinar sodium, on concordant hamster-to-rat cardiac xenografts. Transplant Proc 1992 0.80
158 Structure and repertoire usage of rat TCR alpha-chain genes in T cells infiltrating heart allografts. J Immunol 1995 0.80
159 Amelioration of normothermic canine liver ischemia with prostacyclin. Transplant Proc 1988 0.79
160 Immunomagnetic T-lymphocyte depletion (ITLD) of rat bone marrow using OX-19 monoclonal antibody. J Invest Surg 1989 0.79
161 Effect of cyclosporine on hepatic cytosolic estrogen and androgen receptor levels before and after partial hepatectomy. Dig Dis Sci 1990 0.79
162 Immunosuppression in organ transplantation. Semin Pediatr Surg 1993 0.79
163 Transjugular intrahepatic portosystemic shunt: a nonoperative approach to life-threatening variceal bleeding. Can J Surg 1987 0.79
164 Pelvic exenteration for advanced primary and recurrent adenocarcinoma. Can J Surg 1985 0.79
165 An experimental method for rapid growth of liver in spleen. The survival and proliferation of chemically induced preneoplastic hepatocytes in spleen. Am J Pathol 1983 0.79
166 Prostaglandin E2 prevents fulminant hepatitis and the induction of procoagulant activity in susceptible animals. Transplant Proc 1987 0.79
167 Effect of cimetidine, ranitidine, famotidine and omeprazole on hepatocyte proliferation in vitro. J Hepatol 1989 0.79
168 Genetic control of the humoral immune response to xenografts. II. Monoclonal antibodies that cause rejection of heart xenografts are encoded by germline immunoglobulin genes. Transplantation 1995 0.79
169 Liver transplantation for alcoholic liver disease: a consideration of reasons for and against. Alcohol Clin Exp Res 1989 0.79
170 Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression. Transplantation 1994 0.79
171 Identification of the Aldehydic Metabolites. Transplant Proc 1988 0.79
172 The Denver-Pittsburgh liver transplant series. Clin Transpl 1987 0.79
173 The effect of FK 506 on small intestine allotransplantation in the rat. Transplant Proc 1990 0.79
174 Liver regeneration in rats treated with the antiandrogen flutamide. J Invest Surg 1988 0.79
175 Hepatic resection for malignancy in the elderly. Am Surg 1995 0.79
176 Accelerated graft arteriosclerosis is enhanced by sensitization of the recipient to donor lymphocytes. Transplant Proc 1989 0.78
177 Allogeneic intrasplenic hepatocyte transplantation in the Gunn rat using cyclosporine A immunosuppression. Transplant Proc 1987 0.78
178 Conjugative drug metabolism in liver transplant patients. Transplant Proc 1989 0.78
179 Infections in pediatric liver recipients treated for acute rejection. Transplant Proc 1989 0.78
180 Protective effect of polyethylene glycol-conjugated superoxide dismutase for cold ischemia-reperfusion damage in isolated pig livers. Transplant Proc 1993 0.78
181 Pig aortic endothelial cell antigens recognized by human IgM natural antibodies. Transplantation 1993 0.78
182 Differential usage of the T cell receptor repertoire for allorecognition of heart, liver, and kidney grafts. Transplantation 1995 0.78
183 Detection of hepatitis C virus with RNA polymerase chain reaction in fulminant hepatic failure. Hepatology 1995 0.78
184 Primary cultures of human intrahepatic (biliary) epithelial cells. Transplant Proc 1988 0.78
185 Malignant vascular tumors of the liver presenting as liver failure and portal hypertension. Liver Transpl Surg 1995 0.78
186 The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat. Transplantation 1993 0.78
187 Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival. J Heart Lung Transplant 1994 0.78
188 Prolonged xenograft survival following combination therapy with brequinar sodium and cyclosporine. Transplant Proc 1993 0.77
189 Effect of ranitidine on acetaminophen-induced hepatotoxicity in dogs. Dig Dis Sci 1990 0.77
190 Effect of tamoxifen on hepatic regeneration in male rats. Dig Dis Sci 1989 0.77
191 Effect of radiofrequency hyperthermia and chemotherapy on primary and secondary hepatic malignancies when used with metronidazole. Surgery 1983 0.77
192 Does hyperprolactinemia affect hepatic regeneration independent of sex steroids? J Lab Clin Med 1988 0.77
193 Biliary tract complications in orthotopic adult liver transplantation. Am J Surg 1989 0.77
194 Inhibition of the pyrimidine biosynthetic pathway with S-8660, an analogue of brequinar sodium, prolongs cardiac allograft survival in rats. J Heart Lung Transplant 1993 0.77
195 Genetic control of the humoral immune response to xenografts. I. Functional characterization of rat monoclonal antibodies to hamster heart xenografts. Transplantation 1995 0.77
196 Immunodepletion in xenotransplantation. J Invest Surg 1990 0.77
197 A polymerase chain reaction-based enzyme-linked immunosorbent assay for relative quantitation of T cell receptor beta-gene expression. Its application to the analysis of T cell receptor repertoire usage in alloreactive responses. Transplantation 1994 0.77
198 Differential patterns of reaction of human natural antibodies to pig hepatocytes and vascular endothelium. Liver Transpl Surg 1995 0.77
199 Preoperative serum levels of wild-type and hepatitis B e antigen-negative hepatitis B virus (HBV) and graft infection after liver transplantation for HBV-related hepatocellular carcinoma. J Viral Hepat 1997 0.77
200 Effect of brequinar sodium on in vivo antibody production. Transplant Proc 1993 0.77
201 Correlation between dose and level of cyclosporine after orthotopic liver transplantation. Transplant Proc 1989 0.77
202 The effect of protein depletion upon tumor growth and host survival. J Surg Res 1982 0.77
203 Inhibition of free radical generation and improved survival by protection of the hepatic microvascular endothelium by targeted erythrocytes in orthotopic rat liver transplantation. Transplantation 1990 0.77
204 The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium. Transplantation 1993 0.77
205 Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT). Int J Artif Organs 1992 0.76
206 Clinical considerations in orthotopic liver transplantation. Radiol Clin North Am 1987 0.76
207 Prostaglandin E2 (PGE2) alters the pathogenesis of MHV-3 infection in susceptible BALB/cJ mice. Adv Exp Med Biol 1987 0.76
208 Response of normal and reperfused livers to glucagon stimulation: NMR detection of blood flow and high-energy phosphates. Biochim Biophys Acta 1993 0.76
209 Hepatic artery reconstruction for hepatic artery thrombosis after orthotopic liver transplantation. Arch Surg 1990 0.76
210 Combination therapy for resectable and unresectable adenocarcinoma of the pancreas. Cancer 1986 0.76
211 The use of brequinar sodium for transplantation. Ann N Y Acad Sci 1993 0.76
212 Human serum reactivity to porcine endothelial cells after antisense-mediated down-regulation of GpIIIa expression. Transplantation 1997 0.76
213 A modified technique of orthotopic transplant of the kidney in rabbits. J Invest Surg 1989 0.75
214 Prevention of liver allograft rejection in rats by a short course of therapy with Brequinar Sodium. Transplantation 1992 0.75
215 Liver transplantation for hereditary tyrosinemia in the presence of hepatocellular carcinoma. Transplant Proc 1989 0.75
216 Evaluation of three cytomegalovirus infection prophylactic regimens in liver transplant recipients. Transplant Proc 1992 0.75
217 Organ transplantation--then and now. Hosp Physician 1987 0.75
218 The effect of different types of hepatic injury on the estrogen and androgen receptor activity of liver. J Invest Surg 1989 0.75
219 Plasma lecithin/cholesterol acyltransferase (LCAT) activity in multiple-organ donors: a predictor of allograft viability in clinical liver transplantation. Transplant Proc 1990 0.75
220 Establishment of Primary Cultures of Human Biliary Epithelium and Induction of Class II Major Histocompatibility Complex Antigens by Interferon Gamma. Transplant Proc 1988 0.75
221 Cyclosporine Metabolite Profiles in the Blood of Liver Transplant Patients. Transplant Proc 1988 0.75
222 Effect of partial portal vein ligation on hepatic regeneration. J Invest Surg 1988 0.75
223 Isolation and Partial Purification of Hepatic Stimulatory Substance. Transplant Proc 1988 0.75
224 Response of cultured hepatocytes to a hepatomitogen after initiation by conditioned medium or other factors. Cancer Res 1989 0.75
225 The use of pulmonary artery sequestration as an hepatic arterial conduit. A case of unusual hepatic arterial supply. Transplantation 1989 0.75
226 Sensitization to low dose 5-fluorouracil. Subsequent enhancement of its systemic antitumor effect in the rat. J Clin Invest 1982 0.75
227 [Long-term results of orthotopic liver transplantation during the cyclosporin era. 393 orthotopic liver transplantations accomplished in 313 consecutive patients at the Pittsburgh Transplantation Center]. Helv Chir Acta 1989 0.75
228 Lymphoma and hypercalcemia in a pediatric orthotopic liver transplant patient. Transplantation 1989 0.75
229 Caroli's disease: case report and management recommendations. Can Med Assoc J 1981 0.75
230 Estrogen and androgen receptors in the liver after orthotopic liver transplantation. Transplant Proc 1989 0.75
231 The Protective Effect of SRI 63-441 on Ischemic Liver Injury Using the Isolated Perfused Rat Liver: Combined Protocol With Superoxide Dismutase. Transplant Proc 1988 0.75
232 Pretransplant assessment of human liver grafts by plasma lecithin: cholesterol acyltransferase (LCAT) activity in multiple organ donors. Transpl Int 1992 0.75
233 Improved method of porcine renal allografting for transplantation research. J Invest Surg 1991 0.75
234 Effect of antiandrogen flutamide on measures of hepatic regeneration in rats. Dig Dis Sci 1989 0.75
235 A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat. Transplant Proc 1993 0.75
236 Prevention of vascularized allograft and xenograft rejection in rodents by brequinar sodium. Transplant Proc 1993 0.75
237 Germline VH gene usage in xenoreactive monoclonal antibody. Transplant Proc 1996 0.75
238 The rejection of hamster xenografts by rats is mediated by a restricted repertoire of Ig heavy chain variable genes. Transplant Proc 1996 0.75
239 Survey results of transplant patients' attitudes on xenografting. Psychosomatics 1998 0.75
240 Phase I safety and pharmacokinetic studies of brequinar sodium after single ascending oral doses in stable renal, hepatic, and cardiac allograft recipients. J Clin Pharmacol 1997 0.75
241 Distribution of xenogeneic target antigens detected by a monoclonal antibody capable of inducing hyperacute rejection of hamster cardiac xenografts in rats. Transplant Proc 1994 0.75
242 Excision of abdominal wall tumours and reconstruction with Marlex mesh. Can J Surg 1986 0.75
243 Selective immune stimulation during induction of allograft tolerance in the rat by radical immunosuppression. Transplantation 1980 0.75
244 Radiofrequency hyperthermia as adjuvant therapy following surgical resection of an experimental malignant neoplasm. Cancer 1985 0.75
245 Humoral responses to xenografts: do concordant and discordant reactions share common immune responses? Transplant Proc 1997 0.75
246 Pathogenesis of xenograft reactions in rodents and other small laboratory species. Transplant Proc 1993 0.75
247 Brequinar sodium suppresses liver allograft rejection and induces permanent tolerance in the rat. Transplant Proc 1993 0.75
248 Transplantation of hepatocytes from normal and preneoplastic livers into spleens of syngeneic host rats. Transplantation 1983 0.75
249 Relationship between the dose and whole blood level of cyclosporine after liver and kidney transplantation. J Clin Lab Immunol 1992 0.75
250 Allogeneic and xenogeneic hepatocyte transplantation. Transplant Proc 1981 0.75
251 Cyclosporine A fails to alter innate host resistance to murine hepatitis virus strain 3 infection in A/J mice. Transplant Proc 1987 0.75
252 Polymerase chain reaction detection of chimerism in rats based on an allelic polymorphism for T cell antigen receptor C beta genes. Transpl Immunol 1994 0.75
253 [Genetic control of humoral immune response to xenografts. A monoclonal antibody that causes the hyperacute rejection of cardiac xenografts uses the genes in a native form]. Chirurgie 1996 0.75
254 Reversal of hyperglobulinemia after orthotopic liver transplantation. N Engl J Med 1989 0.75
255 Pediatric liver transplantation. Semin Pediatr Surg 1993 0.75
256 Thermochemotherapy for unresectable hepatic cancer. Recent Results Cancer Res 1986 0.75
257 Mechanisms of altered in vitro antibody response in the rat by a small synthetic polymer. Scand J Immunol 1982 0.75
258 Mechanism of enhanced humoral response in rodents by a synthetic polymer. J Immunopharmacol 1983 0.75
259 Aminopyrine metabolism in cryopreserved isolated rat hepatocytes. Can J Physiol Pharmacol 1981 0.75
260 Enhanced survival in antibiotic-treated murine fecal peritonitis by administration of copovithane, a selective immunostimulative polymer. J Surg Res 1985 0.75
261 Palliation of advanced head and neck cancer with radiofrequency hyperthermia and cytotoxic chemotherapy. Can J Surg 1984 0.75
262 Sclerotherapy for esophageal varices: preliminary experience. Can J Surg 1984 0.75
263 Target antigen specificity of a monoclonal antibody (HAR-1) that causes the rejection of hamster heart xenografts in rats. Transplant Proc 1995 0.75
264 Inhibition of in vitro immunoglobulin production by a novel immunosuppressive drug brequinar sodium. Transplant Sci 1994 0.75
265 Successful treatment of a traumatic hepatic artery-portal vein arteriovenous fistula by interpositional mesocaval shunting. Can J Surg 1987 0.75
266 Approach to hepatic metastases from colorectal adenocarcinoma. Semin Liver Dis 1988 0.75
267 The effect of portal diversion on the early stages of liver carcinogenesis in the rat. Hepatology 1982 0.75
268 Intragraft cytokine gene expression in human liver allografts. Liver Transpl Surg 1995 0.75
269 Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation. Transplant Proc 1996 0.75
270 Use of liver cytosol fractions in treatment of acute liver failure. Surgery 1982 0.75
271 Effects of brequinar sodium on cynomolgus monkeys: immunosuppression and pharmacokinetics. Transplant Proc 1993 0.75
272 Hyperthermia as a treatment for neoplasia. Can J Surg 1982 0.75
273 Failure of liver transplantation to diminish cardiac deposits of amylopectin and leukocyte inclusions in type IV glycogen storage disease. Liver Transpl Surg 1995 0.75
274 Comparative immunopathologic study of hyperacute rejection in naive and sensitized rodent cardiac xenograft models. Transplant Proc 1993 0.75
275 Enhanced oral cyclosporine absorption with water-soluble vitamin E early after liver transplantation. Pharmacotherapy 1996 0.75
276 Immunochemical characterization of the binding of human immunoglobulins to pig vascular endothelium. Transplant Proc 1992 0.75
277 Hyperthermochemotherapeutic in vivo isolated perfusion of the rat liver. Cancer 1983 0.75
278 The effect of radiofrequency hyperthermia and chemotherapy upon human neoplasms when used with adjuvant metronidazole. Surg Gynecol Obstet 1983 0.75
279 Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium. Transplant Proc 1993 0.75
280 Intermittent percutaneous infusion into the hepatic artery of cytotoxic drugs for hepatic tumours. Can J Surg 1982 0.75
281 Adenocarcinoma of the trachea: palliative response to cobalt-60 irradiation. Can J Surg 1979 0.75
282 Evidence for inbreeding, MHC haplotype matching, and prolonged kidney graft survival in Yucatan miniature swine. Transplantation 1993 0.75
283 Immunosuppression: now we have choices. Hepatology 1995 0.75
284 Endothelial cell antigens associated with accelerated cardiac graft rejection in the rat. Transplant Proc 1995 0.75
285 Transjugular intrahepatic portosystemic shunt: efficacy for the treatment of portal hypertension and impact on liver transplantation. Am Surg 1996 0.75
286 Adjuvant chemoimmunotherapy for gastric carcinoma. Can J Surg 1980 0.75
287 Cardiac hyperacute rejection in concordant xenograft combinations induced by immunization. Transplant Proc 1992 0.75
288 Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection. Transplant Proc 1993 0.75
289 Characterization of human antibodies that are cytotoxic to pig aortic endothelial cells. Transplant Proc 1993 0.75
290 The effect of preservation fluid on the blood flow of pediatric liver allografts. Transplantation 1989 0.75
291 Neurologic improvement of patients with hepatic failure and coma during sorbent suspension dialysis. ASAIO Trans 1992 0.75
292 Percutaneous transhepatic sphincterotomy in the management of biliary tract disease. Gastrointest Radiol 1986 0.75
293 Elimination of 51Cr-labelled target cells as a method of in vivo assessment of immune reactions. Folia Biol (Praha) 1981 0.75
294 Neurological and psychological sequelae in transplant recipients after bridging with the bioartificial liver. Gen Hosp Psychiatry 1996 0.75
295 Liver transplantation today. Postgrad Med 1987 0.75
296 Clinical evaluation of a synthetic low molecular weight polymer for advanced gastrointestinal cancer. Clin Invest Med 1981 0.75
297 Resistance to murine hepatitis virus strain 3 (MHV-3) infection in A/J mice is not affected by cyclosporin A (CsA). Adv Exp Med Biol 1987 0.75
298 Comparison of in-vivo thermochemotherapy of isolated rat liver through portal vein and hepatic artery. Can J Surg 1983 0.75